Cyclacel Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.64M, a 38.5% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$20.2M, a 29.3% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$25.5M, a 7.97% increase from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.7M, a 23.5% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$22.4M, a 111% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.5M +$2.2M +7.97% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$27.7M -$5.27M -23.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$22.4M -$11.8M -111% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 -$10.6M -$954K -9.85% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$9.68M -$134K -1.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$9.55M -$57K -0.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$9.49M +$4.66M +32.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 -$14.2M +$2.02M +12.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$16.2M +$6.27M +27.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$22.4M -$4.46M -24.8% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 -$18M -$2.87M -19% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$15.1M +$645K +4.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 -$15.7M -$613K -4.05% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 -$15.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.